Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs

Xiaokang Zhang, Qing Zhang(South China University of Technology), Jingyuan Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Zhang(Shihezi University), Xiaolei Hu(Shanghai Jiao Tong University), Junnian Zheng(Xuzhou Medical College), Chao Huang(Xuzhou Medical College), Yangna Miao(Xuzhou Medical College), Bixi Wang(Xuzhou Medical College), Xiaohuan Wei(Xuzhou Medical College), Hailong Li(Central South University), Yifan Yuan(Xuzhou Medical College), Heng Xu(Xuzhou Medical College), Shishuo Sun(Xuzhou Medical College), Wanxin Zhao(Xuzhou Medical College), Xiaoge Gao(Xuzhou Medical College)
Journal of Cancer Research and Clinical Oncology
August 12, 2022
Cited by 24


Related Papers